Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Srinivasan, Venkatachalam"'
Autor:
Christian, Gnanaraj Johnson, Meenakumari, Ramasamy, Shanthimalar, Ramalingam, Sankar, Ganesan, Ravichandran, Vadugam Muthusamy, Elansekaran, Selladurai, Ramamurthy, Murugan, Srinivasan, Venkatachalam, Rajalakshmi, Elumalai, Boopathi, Kangusamy, Vennila, Kesavan, Nijavizhi, Mohanasundaram, Shakthi Paargavi, Ambalavanan, Aruldevi, Selvam, Priyanka, Sekaran, Gajalakshmi, Govindasamy
Publikováno v:
In Journal of Ayurveda and Integrative Medicine March-April 2023 14(2)
Autor:
Arvind Nune, Victor Durkowski, S. Sujitha Pillay, Bhupen Barman, Helen Elwell, Kaustubh Bora, Syed Bilgrami, Sajid Mahmood, Nasarulla Babajan, Srinivasan Venkatachalam, Lesley Ottewell, Ciro Manzo
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1571 (2023)
A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking. Therefore, we investigated the demographics, management, and prognosis of new R-
Externí odkaz:
https://doaj.org/article/40a1beafa21341ff802406707cff1eec
Autor:
Ernest Choy, Lara Groves, Daniel Sugrue, Michael Hurst, John Houghton, Srinivasan Venkatachalam, Yusuf I. Patel, James R. Maxwell, Kevin G. Pollock, Sadie Henning
Publikováno v:
BMC Rheumatology, Vol 5, Iss 1, Pp 1-12 (2021)
Abstract Background Rheumatoid arthritis (RA) is an inflammatory autoimmune disease that causes chronic synovitis, resulting in progressive joint destruction and functional disability and affects approximately 400,000 people in the UK. This real-worl
Externí odkaz:
https://doaj.org/article/e9d5ecbef25f482aa902590c6d5d49b0
Publikováno v:
Rheumatology. 62
Background/Aims Tapering biologic therapies in patients with rheumatoid arthritis (RA) is evolving. Our primary objective was to combine clinical and ultrasound assessment in selecting patients with RA for tapering biologic therapies. The secondary o
Autor:
Adeola Ajibade, Ashley Hawarden, Annabelle Leong, George Hirsch, Tochukwu Adizie, Srinivasan Venkatachalam
Publikováno v:
Rheumatology. 62
Background/Aims Tofacitinib and baricitinib were the first orally available, targeted synthetic Janus kinase (JAK) inhibitors approved for the treatment of rheumatoid arthritis (RA) in the UK. Evidence suggests that JAK inhibitors are as efficacious
Autor:
Arvind Nune, Kaustubh Bora, Karthikeyan P Iyengar, Bhupen Barman, Victor Durkowski, Srinivasan Venkatachalam, Syed Mujtaba Haider Bilgrami, Lesley Ottewell, Ciro Manzo
Publikováno v:
Rheumatology. 62
Background/Aims There are sporadic reports about the development of new rheumatic immune-mediated inflammatory diseases (R-IMIDs) in adults after receiving SARS-CoV-2 vaccines. This systematic review (SR) aimed to critically review and summarize the
Autor:
Vinodhini Thamilarasan, Shakthi Paargavi Ambalavanan, Elansekaran Selladurai, Ramamurthy Murugan, Srinivasan Venkatachalam, Christian Gnanaraj Johnson
Publikováno v:
International Journal of Ayurvedic Medicine. 13:22-27
Background: On March 12, 2020, WHO declared Novel Coronavirus disease as a pandemic outbreak all over the world. The outbreak had led the medical sector to a new platform, in the implementation of ancient knowledge of the Siddha medicine in treatment
Autor:
Gunasekaran, Dhanapal, Srinivasan, Venkatachalam, Vignesh, Manoharan, Shantharam, Yuvaraj, Gnanapriya, Gnanasekaran
Publikováno v:
AIP Conference Proceedings; 2023, Vol. 2782 Issue 1, p1-7, 7p